REL and cancer: With regards to the assessed overexpression of c-REL in human cancers (Fig 1A), potential clinical implications of the c-REL knockout were assessed by determining cell survival upon exposure to the chemotherapeutic agents 5-Fluoro-2’-deoxyuridine (5-FUDR) and cisplatin.